Internet Delivered CBT for Body Dysmorphic Disorder

Not Applicable

Completed

• Conditions: BDD; Body Dysmorphic Disorder
• Interventions: Behavioral: Cognitive behavior therapy; Behavioral: Supportive therapy

• Registration Number: NCT02010619
• Lead Sponsor: Karolinska Institutet

Brief Summary

To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment when compared to a control group consisting of supportive therapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-11
• Study First Submitted: 2013-11-18
• Study First Submitted QC: 2013-12-12
• Study First Posted: 2013-12-13
• Primary Completion: 2015-01
• Study Completion: 2015-01
• Status Verified: 2017-08
• Last Update Submitted: 2017-08-15
• Last Update Posted: 2017-08-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 94

Inclusion Criteria

• outpatient
• ≥ 18 years
• primary diagnosis of BDD according to the DSM-5
• BDD-YBOCS ≥20
• regular access to a computer with Internet access and skills to use the web.

Exclusion Criteria

• psychotropic medication changes within two months prior to the treatment,
• completed CBT for BDD within the last 12 months,
• other primary axis I diagnosis
• current substance dependence
• lifetime bipolar disorder or psychosis
• suicidal ideation
• Axis II diagnosis that could jeopardize treatment participation,
• other current psychological treatment that could affect BDD symptoms
• A serious medical illness that precludes participation in the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Cognitive behavior therapy	Cognitive behavior therapy	-
Supportive therapy	Supportive therapy	-

Primary Outcome Measures

Name	Time	Method
Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS)	Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12)

Secondary Outcome Measures

Name	Time	Method
The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S)	Change in MADRS-S from baseline (week 0) to post-treatment (week 12)

Trial Locations

Locations (1)

M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst; 🇸🇪 Stockholm, Huddinge, Sweden